KL4 Surfactant is under clinical development by Windtree Therapeutics and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome.
Cell: Coronavirus hijacks cells' virus-killing tools to promote its own spread AstraZeneca's "Glycopyrrolate Formoterol Inhalation Aerosol" is approved for marketing The growth rate of retail drug ...
Dr Asem Suresh Kumar MeiteiContd from previous issueBut the actual number of loss from rabies among livestock in India cannot be ruled out as the reporting system is grossly deficient.Transmission Dyn ...
It's likely that you have either had the delightful experience of having to remove a virus, or are currently going through said experience, so to cut through the noise we have rounded up all of ...